Michael Henderson is the founder of Apogee Therapeutics. Apogee Therapeutics has raised $169M in total funding. Latest round: Series B. Based in Waltham, MA.
Michael Henderson, M.D., is the Chief Executive Officer and a Board member of Apogee Therapeutics, a biotechnology company focused on developing therapies for immunological and inflammatory disorders. The company launched with an initial $169 million, including a $149 million Series B financing. Apogee Therapeutics is a spinout company from Paragon Therapeutics and is advancing a pipeline of product candidates, with its lead program APG777 expected to enter the clinic in 2023.
Full founder directory · Investor directory · Company funding database · Fundraising library